Senator launches new models to manage costs of weight-loss drugs like Ozempic
WASHINGTON With blockbuster sales of Novo Nordisks Wegovy and Ozempic and the approval of a new rival this week, everyone in Washington is thinking about how to deal with the surging tide of weight-loss drug costs. Explosive national demand for weight management therapies and diabetes drugs like Ozempic, all of… Continue Reading Senator launches new models to manage costs of weight-loss drugs like Ozempic